These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 38941713)

  • 1. Practice Patterns of Glucagon-Like Peptide-1 Agonist Use Among Pediatric Bariatric Surgeons: A National Survey.
    Kochis M; Bizimana C; Zitsman JL; Pratt JSA; Griggs CL
    J Surg Res; 2024 Sep; 301():172-179. PubMed ID: 38941713
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bariatric surgery practice patterns among pediatric surgeons in the United States.
    Lewit RA; Harmon CM; Ricca R; Rich BS; Raval MV; Weatherall YZ
    J Pediatr Surg; 2022 Dec; 57(12):887-891. PubMed ID: 35927071
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regional Variations in Pediatric Metabolic and Bariatric Surgeon Availability: A Call for Action.
    Liang NE; Perez NP; Singhal V; Pratt JSA; Zitsman J; Griggs CL
    J Surg Res; 2024 Mar; 295():522-529. PubMed ID: 38086252
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Post metabolic bariatric surgery weight regain: the importance of GLP-1 levels.
    Çalık Başaran N; Dotan I; Dicker D
    Int J Obes (Lond); 2024 Jan; ():. PubMed ID: 38225284
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of glucagon-like peptide-1 receptor agonists in eating disorder populations.
    Bartel S; McElroy SL; Levangie D; Keshen A
    Int J Eat Disord; 2024 Feb; 57(2):286-293. PubMed ID: 38135891
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of GLP-1 agonists in high risk patients prior to bariatric surgery: a cohort study.
    Ilanga M; Heard JC; McClintic J; Lewis D; Martin G; Horn C; Khorgami Z; Richards J; Chow GS; Lim RB
    Surg Endosc; 2023 Dec; 37(12):9509-9513. PubMed ID: 37700013
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical insights into management options for recurrent type 2 diabetes and cardiovascular risk after metabolic-bariatric surgery.
    Lupoli R; Lembo E; Giosuè A; Schiavo L; Capaldo B
    Nutr Metab Cardiovasc Dis; 2022 Jun; 32(6):1335-1342. PubMed ID: 35365370
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preoperative weight loss with glucagon-like peptide-1 receptor agonist treatment predicts greater weight loss achieved by the combination of medical weight management and bariatric surgery in patients with type 2 diabetes: A longitudinal analysis.
    Tang T; Abbott S; le Roux CW; Wilson V; Singhal R; Bellary S; Tahrani AA
    Diabetes Obes Metab; 2018 Mar; 20(3):745-748. PubMed ID: 29053203
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PREscribing preoperative weight loss prior to major non-bariatric abdominal surgery for patients with Elevated weight: Patient and Provider Survey Protocols (PREPARE surveys).
    McKechnie T; Saddik M; Doumouras A; Eskicioglu C; Parpia S; Bhandari M
    PLoS One; 2024; 19(4):e0302482. PubMed ID: 38687754
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ASMBS pediatric metabolic and bariatric surgery guidelines, 2018.
    Pratt JSA; Browne A; Browne NT; Bruzoni M; Cohen M; Desai A; Inge T; Linden BC; Mattar SG; Michalsky M; Podkameni D; Reichard KW; Stanford FC; Zeller MH; Zitsman J
    Surg Obes Relat Dis; 2018 Jul; 14(7):882-901. PubMed ID: 30077361
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Major adverse cardiovascular events among patients with type-2 diabetes, a nationwide cohort study comparing primary metabolic and bariatric surgery to GLP-1 receptor agonist treatment.
    Stenberg E; Näslund E
    Int J Obes (Lond); 2023 Apr; 47(4):251-256. PubMed ID: 36670155
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of glucagon-like peptide-1 receptor agonists for pediatric patients with obesity and diabetes: The providers' perspectives.
    Gourgari E; Huerta-Saenz L; Tonyushkina KN; Rosolowsky ET; Guttmann-Bauman I
    Pediatr Diabetes; 2021 Sep; 22(6):872-875. PubMed ID: 34018306
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metabolic and Bariatric Surgery in Adolescents: For Whom, When, and How?
    Janson A; Järvholm K; Sjögren L; Dahlgren J; Beamish AJ; Gronowitz E; Olbers T
    Horm Res Paediatr; 2023; 96(6):609-619. PubMed ID: 35263750
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bariatric and metabolic surgery in patients with low body mass index: an online survey of 543 bariatric and metabolic surgeons.
    Shahmiri SS; Parmar C; Yang W; Lainas P; Pouwels S; DavarpanahJazi AH; Chiappetta S; Seki Y; Omar I; Vilallonga R; Kassir R; Abbas SI; Bashir A; Singhal R; Kow L; Kermansaravi M
    BMC Surg; 2023 Sep; 23(1):272. PubMed ID: 37689633
    [TBL] [Abstract][Full Text] [Related]  

  • 15. GLP-2 receptor signaling controls circulating bile acid levels but not glucose homeostasis in Gcgr
    Patel A; Yusta B; Matthews D; Charron MJ; Seeley RJ; Drucker DJ
    Mol Metab; 2018 Oct; 16():45-54. PubMed ID: 29937214
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Improving Access to Child and Adolescent Weight Loss Surgery: A Review of Updated National and International Practice Guidelines.
    Elkhoury D; Elkhoury C; Gorantla VR
    Cureus; 2023 Apr; 15(4):e38117. PubMed ID: 37252536
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Healthcare professionals' perceptions and management of obesity & knowledge of glucagon, GLP-1, GIP receptor agonists, and dual agonists.
    Garvey WT; Mahle CD; Bell T; Kushner RF
    Obes Sci Pract; 2024 Jun; 10(3):e756. PubMed ID: 38708040
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Indications and Coverage of Metabolic and Bariatric Surgery: A Worldwide IFSO Survey Comparing Different National Guidelines.
    Pujol-Rafols J; Carmona-Maurici J; Felsenreich DM; Shikora SA; Prager G; Di Lorenzo N; De Luca M; Uyanik O; Mazzarella M; D'Arco S; Angrisani L; Pardina E; Balibrea JM
    Obes Surg; 2024 May; 34(5):1395-1404. PubMed ID: 38472706
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Narrative Review of Effects of Glucagon-Like Peptide-1 Receptor Agonists on Bone Health in People Living with Obesity.
    Herrou J; Mabilleau G; Lecerf JM; Thomas T; Biver E; Paccou J
    Calcif Tissue Int; 2024 Feb; 114(2):86-97. PubMed ID: 37999750
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Postprandial plasma GLP-1 levels are elevated in individuals with postprandial hypoglycaemia following Roux-en-Y gastric bypass - a systematic review.
    Jalleh RJ; Umapathysivam MM; Plummer MP; Deane A; Jones KL; Horowitz M
    Rev Endocr Metab Disord; 2023 Dec; 24(6):1075-1088. PubMed ID: 37439960
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.